{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:55Z","timestamp":1794047455117,"version":"4.8.0"},"reference-count":51,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"5","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Burkitt lymphoma cells (BL) exploit antigen-independent tonic signals transduced by the B-cell antigen receptor (BCR) for their survival, but the molecular details of the rewired BL-specific BCR signal network remain unclear. A loss of function screen revealed the SH2 domain-containing 5`-inositol phosphatase 2 (SHIP2) as a potential modulator of BL fitness. We characterized the role of SHIP2 in BL survival in several BL cell models and show that perturbing SHIP2 function renders cells more susceptible to apoptosis, while attenuating proliferation in a BCR-dependent manner. Unexpectedly, SHIP2 deficiency did neither affect PI3K survival signals nor MAPK activity, but attenuated ATP production. We found that an efficient energy metabolism in BL cells requires phosphatidylinositol-3,4-bisphosphate (PI(3,4)P2), which is the enzymatic product of SHIP proteins. Consistently, interference with the function of SHIP1 and SHIP2 augments BL cell susceptibility to PI3K inhibition. Notably, we provide here a molecular basis of how tonic BCR signals are connected to energy supply, which is particularly important for such an aggressively growing neoplasia. These findings may help to improve therapies for the treatment of BL by limiting energy metabolism through the inhibition of SHIP proteins, which renders BL cells more susceptible to the targeting of survival signals.<\/jats:p>","DOI":"10.3324\/haematol.2023.283663","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T04:08:16Z","timestamp":1698898096000},"page":"1445-1459","source":"Crossref","is-referenced-by-count":1,"title":["SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism"],"prefix":"10.3324","volume":"109","author":[{"given":"Florian","family":"Mayr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik C.","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"L\u00f6ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saed","family":"Alsouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Paglilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Chapuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Br\u00fcne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Zenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"H\u00e4upl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Oellerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Engelke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"60543","doi-asserted-by":"crossref","unstructured":"Taub R, Kirsch I, Morton C. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A. 1982; 79(24):7837-7841.","DOI":"10.1073\/pnas.79.24.7837"},{"key":"60544","doi-asserted-by":"crossref","unstructured":"Schmitz R, Young RM, Ceribelli M. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012; 490(7418):116-120.","DOI":"10.1038\/nature11378"},{"key":"60545","doi-asserted-by":"crossref","unstructured":"Lam K-P, K\u00fchn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell. 1997; 90(6):1073-1083.","DOI":"10.1016\/S0092-8674(00)80373-6"},{"key":"60546","doi-asserted-by":"crossref","unstructured":"He X, Kl\u00e4sener K, Iype JM. Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells. EMBO J. 2018; 37(11):e97980.","DOI":"10.15252\/embj.201797980"},{"key":"60547","doi-asserted-by":"crossref","unstructured":"Richter J, Schlesner M, Hoffmann S. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet. 2012; 44(12):1316-1320.","DOI":"10.1038\/ng.2469"},{"key":"60548","doi-asserted-by":"crossref","unstructured":"Love C, Sun Z, Jima D. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012; 44(12):1321-1325.","DOI":"10.1038\/ng.2468"},{"key":"60549","doi-asserted-by":"crossref","unstructured":"Hsu L-Y, Lauring J, Liang H-E. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity. 2003; 19(1):105-117.","DOI":"10.1016\/S1074-7613(03)00181-X"},{"key":"60550","doi-asserted-by":"crossref","unstructured":"Beck K, Peak MM, Ota T, Nemazee D, Murre C. Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci. J Exp Med. 2009; 206(10):2271-2284.","DOI":"10.1084\/jem.20090756"},{"key":"60551","doi-asserted-by":"crossref","unstructured":"Walter R, Pan K-T, Doebele C. HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling. Blood. 2017; 129(5):598-608.","DOI":"10.1182\/blood-2016-06-721423"},{"key":"60552","doi-asserted-by":"crossref","unstructured":"Sander S, Calado DP, Srinivasan L. Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell. 2012; 22(2):167-179.","DOI":"10.1016\/j.ccr.2012.06.012"},{"key":"60553","doi-asserted-by":"crossref","unstructured":"Gehringer F, Weissinger SE, M\u00f6ller P, Wirth T, Ushmorov A. Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma. Leukemia. 2020; 34(3):857-871.","DOI":"10.1038\/s41375-019-0628-0"},{"key":"60554","doi-asserted-by":"crossref","unstructured":"Liu C, Miller H, Hui KL. A balance of Bruton\u2019s tyrosine kinase and SHIP activation regulates B cell receptor cluster formation by controlling actin remodeling. J Immunol. 2011; 187(1):230-239.","DOI":"10.4049\/jimmunol.1100157"},{"key":"60555","doi-asserted-by":"crossref","unstructured":"Neumann K, Oellerich T, Heine I, Urlaub H, Engelke M. Fc gamma receptor IIb modulates the molecular Grb2 interaction network in activated B cells. Cell Signal. 2011; 23(5):893-900.","DOI":"10.1016\/j.cellsig.2011.01.015"},{"key":"60556","doi-asserted-by":"crossref","unstructured":"Corso J, Pan K-T, Walter R. Elucidation of tonic and activated B-cell receptor signaling in Burkitt\u2019s lymphoma provides insights into regulation of cell survival. Proc Natl Acad Sci U S A. 2016; 113(20):5688-5693.","DOI":"10.1073\/pnas.1601053113"},{"key":"60557","doi-asserted-by":"crossref","unstructured":"Bagaloni I, Visani A, Biagiotti S. Metabolic switch and cytotoxic effect of metformin on Burkitt lymphoma. Front Oncol. 2021; 11:661102.","DOI":"10.3389\/fonc.2021.661102"},{"key":"60558","doi-asserted-by":"crossref","unstructured":"Schwarzfischer P, Reinders J, Dettmer K. Comprehensive metaboproteomics of Burkitt\u2019s and diffuse large B-cell lymphoma cell lines and primary tumor tissues reveals distinct differences in Pyruvate content and metabolism. J Proteome Res. 2017; 16(3):1105-1120.","DOI":"10.1021\/acs.jproteome.6b00164"},{"key":"60559","doi-asserted-by":"crossref","unstructured":"Wilke AC, Doebele C, Zindel A. SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Blood. 2022; 139(4):538-553.","DOI":"10.1182\/blood.2021012081"},{"key":"60560","doi-asserted-by":"crossref","unstructured":"Ryan J, Montero J, Rocco J, Letai A. iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry. Biol Chem. 2016; 397(7):671-678.","DOI":"10.1515\/hsz-2016-0107"},{"key":"60561","doi-asserted-by":"crossref","unstructured":"Bojarczuk K, Wienand K, Ryan JA. Targeted inhibition of PI3K\u03b1\/\u03b4 is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL. Blood. 2019; 133(1):70-80.","DOI":"10.1182\/blood-2018-08-872465"},{"key":"60562","doi-asserted-by":"crossref","unstructured":"H\u00fcllein J, S\u0142abicki M, Rosolowski M. MDM4 is targeted by 1q gain and drives disease in Burkitt lymphoma. Cancer Res. 2019; 79(12):3125-3138.","DOI":"10.1158\/0008-5472.CAN-18-3438"},{"key":"60563","doi-asserted-by":"crossref","unstructured":"Suwa A, Yamamoto T, Sawada A. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2. Br J Pharmacol. 2009; 158(3):879-887.","DOI":"10.1111\/j.1476-5381.2009.00358.x"},{"key":"60564","unstructured":"Klein E, Klein G, Nadkarni JS, Nadkarni JJ, Wigzell H, Clifford P. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res. 1968; 28(7):1300-1310."},{"key":"60565","doi-asserted-by":"crossref","unstructured":"Klein G, Giovanella B, Westman A, Stehlin JS, Mumford D. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology. 1975; 5(6):319-334.","DOI":"10.1159\/000149930"},{"key":"60566","doi-asserted-by":"crossref","unstructured":"Ben-Bassat H, Goldblum N, Mitrani S. Establishment in continuous culture of a new type of lymphocyte from a \u201cBurkitt like\u201d malignant lymphoma (line D.G.-75). Int J Cancer. 1977; 19(1):27-33.","DOI":"10.1002\/ijc.2910190105"},{"key":"60567","doi-asserted-by":"crossref","unstructured":"Ierano C, Chakraborty AR, Nicolae A. Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitors. Cell Cycle. 2013; 12(17):2829-2838.","DOI":"10.4161\/cc.25914"},{"key":"60568","doi-asserted-by":"crossref","unstructured":"Brahmbhatt H, Uehling D, Al-Awar R, Leber B, Andrews D. Small molecules reveal an alternative mechanism of Bax activation. Biochem J. 2016; 473(8):1073-1083.","DOI":"10.1042\/BCJ20160118"},{"key":"60569","doi-asserted-by":"crossref","unstructured":"Deng J, Carlson N, Takeyama K, Dal Cin P, Shipp M, Letai A. BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell. 2007; 12(2):171-185.","DOI":"10.1016\/j.ccr.2007.07.001"},{"key":"60570","doi-asserted-by":"crossref","unstructured":"Del Gaizo Moore V, Letai A. BH3 profiling--measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions. Cancer Lett. 2013; 332(2):202-205.","DOI":"10.1016\/j.canlet.2011.12.021"},{"key":"60571","doi-asserted-by":"crossref","unstructured":"Sochalska M, Schuler F, Weiss JG, Prchal-Murphy M, Sexl V, Villunger A. MYC selects against reduced BCL2A1\/A1 protein expression during B cell lymphomagenesis. Oncogene. 2017; 36(15):2066-2073.","DOI":"10.1038\/onc.2016.362"},{"key":"60572","unstructured":"Brown J. Effects of 2-deoxyglucose on carbohydrate metablism: review of the literature and studies in the rat. Metabolism. 1962; 11:1098-1112."},{"key":"60573","doi-asserted-by":"crossref","unstructured":"Rom\u00e1n-Fern\u00e1ndez \u00c1, Roignot J, Sandilands E. The phospholipid PI(3,4)P2 is an apical identity determinant. Nat Commun. 2018; 9(1):5041.","DOI":"10.1038\/s41467-018-07464-8"},{"key":"60574","doi-asserted-by":"crossref","unstructured":"Engelberts PJ, Voorhorst M, Schuurman J. Type I CD20 antibodies recruit the B cell receptor for complement-dependent lysis of malignant B cells. J Immunol. 2016; 197(12):4829-4837.","DOI":"10.4049\/jimmunol.1600811"},{"key":"60575","doi-asserted-by":"crossref","unstructured":"Helgason CD, Kalberer CP, Damen JE. A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: aberrant development and enhanced function of b lymphocytes in ship -\/- mice. J Exp Med. 2000; 191(5):781-794.","DOI":"10.1084\/jem.191.5.781"},{"key":"60576","doi-asserted-by":"crossref","unstructured":"Zhou J, Di M, Han H. Upregulation of SHIP2 participates in the development of breast cancer via promoting Wnt\/\u03b2-catenin signaling. Onco Targets Ther. 2019; 12:7067-7077.","DOI":"10.2147\/OTT.S223422"},{"key":"60577","unstructured":"Fu M, Fan W, Pu X. Elevated expression of SHIP2 correlates with poor prognosis in non-small cell lung cancer. Int J Clin Exp Pathol. 2013; 6(10):2185-2191."},{"key":"60578","doi-asserted-by":"crossref","unstructured":"Zhou X, Liu Y, Tan G. Prognostic value of elevated SHIP2 expression in laryngeal squamous cell carcinoma. Arch Med Res. 2011; 42(7):589-595.","DOI":"10.1016\/j.arcmed.2011.10.012"},{"key":"60579","doi-asserted-by":"crossref","unstructured":"Fuhler GM, Brooks R, Toms B. Therapeutic potential of SH2 domain-containing inositol-5\u2019-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer. Mol Med. 2012; 18(1):65-75.","DOI":"10.2119\/molmed.2011.00178"},{"key":"60580","doi-asserted-by":"crossref","unstructured":"Manning BD, Cantley LC. AKT\/PKB signaling: navigating downstream. Cell. 2007; 129(7):1261-74.","DOI":"10.1016\/j.cell.2007.06.009"},{"key":"60581","doi-asserted-by":"crossref","unstructured":"Revathidevi S, Munirajan AK. Akt in cancer: mediator and more. Semin Cancer Biol. 2019; 59:80-91.","DOI":"10.1016\/j.semcancer.2019.06.002"},{"key":"60582","doi-asserted-by":"crossref","unstructured":"Currie RA, Walker KS, Gray A. Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. Biochem J. 1999; 337(Pt 3):575-583.","DOI":"10.1042\/bj3370575"},{"key":"60583","doi-asserted-by":"crossref","unstructured":"Levina A, Fleming KD, Burke JE, Leonard TA. Activation of the essential kinase PDK1 by phosphoinositide-driven transautophosphorylation. Nat Commun. 2022; 13(1):1874.","DOI":"10.1038\/s41467-022-29368-4"},{"key":"60584","doi-asserted-by":"crossref","unstructured":"Ebner M, Lu\u010di\u0107 I, Leonard TA, Yudushkin I. PI(3,4,5)P3 engagement restricts Akt activity to cellular membranes. Mol Cell. 2017; 65(3):416-431.","DOI":"10.1016\/j.molcel.2016.12.028"},{"key":"60585","doi-asserted-by":"crossref","unstructured":"Alessi DR, James SR, Downes CP. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr Biol. 1997; 7(4):261-269.","DOI":"10.1016\/S0960-9822(06)00122-9"},{"key":"60586","doi-asserted-by":"crossref","unstructured":"Stephens L, Anderson K, Stokoe D. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science. 1998; 279(5351):710-714.","DOI":"10.1126\/science.279.5351.710"},{"key":"60587","doi-asserted-by":"crossref","unstructured":"Liu S-L, Wang Z-G, Hu Y. Quantitative lipid imaging reveals a new signaling function of phosphatidylinositol-3,4-bisphophate: isoform- and site-specific activation of Akt. Mol Cell. 2018; 71(6):1092-1104.","DOI":"10.1016\/j.molcel.2018.07.035"},{"key":"60588","doi-asserted-by":"crossref","unstructured":"Schmitz R, Wright GW, Da Huang W. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018; 378(15):1396-1407.","DOI":"10.1056\/NEJMoa1801445"},{"key":"60589","doi-asserted-by":"crossref","unstructured":"Falasca M, Hughes WE, Dominguez V. The role of phosphoinositide 3-kinase C2alpha in insulin signaling. J Biol Chem. 2007; 282(38):28226-28236.","DOI":"10.1074\/jbc.M704357200"},{"key":"60590","doi-asserted-by":"crossref","unstructured":"Le A, Lane AN, Hamaker M. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012; 15(1):110-121.","DOI":"10.1016\/j.cmet.2011.12.009"},{"key":"60591","doi-asserted-by":"crossref","unstructured":"DAvola A, Legrave N, Tajan M. PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. J Clin Invest. 2022; 132(9):e153436.","DOI":"10.1172\/JCI153436"},{"key":"60592","doi-asserted-by":"crossref","unstructured":"George B, Chowdhury SM, Hart A. Ibrutinib resistance mechanisms and treatment strategies for B-cell lymphomas. Cancers (Basel). 2020; 12(5):1328.","DOI":"10.3390\/cancers12051328"},{"key":"60593","doi-asserted-by":"crossref","unstructured":"Ren L, Li L, Zhang L. Ibrutinib in patients with relapsed or refractory diffuse large B-cell lymphoma: a retrospective study. Indian J Hematol Blood Transfus. 2022; 38(1):42-50.","DOI":"10.1007\/s12288-021-01433-w"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283663\/76274","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283663\/76938","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11330\/76274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:11Z","timestamp":1794045911000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283663","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,2]]}}}